--- title: "Warning Letter, Definition | MedTech Terms" description: "Formal FDA notification of significant violations requiring prompt corrective action. Plain-English Quality & Risk definition for MedTech teams, with examples a" lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/warning-letter#term", "name": "Warning Letter", "description": "An FDA Warning Letter is a notice to a regulated entity citing significant violations and requesting prompt corrective action, typically within 15 business days.", "url": "https://medtechterms.com/terms/warning-letter", "termCode": "warning-letter", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/warning-letter#article", "headline": "Warning Letter", "description": "Formal FDA notification of significant violations requiring prompt corrective action.", "url": "https://medtechterms.com/terms/warning-letter", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/warning-letter" }, "about": { "@id": "https://medtechterms.com/terms/warning-letter#term" }, "articleSection": "Quality & Risk", "inLanguage": "en", "keywords": "Warning Letter, Quality & Risk, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "FDA Warning Letters", "url": "https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters", "publisher": { "@type": "Organization", "name": "FDA" } }, { "@type": "CreativeWork", "name": "MDIC Case for Quality", "url": "https://mdic.org/program/case-for-quality/", "publisher": { "@type": "Organization", "name": "MDIC" } }, { "@type": "CreativeWork", "name": "FDA - Quality Systems", "url": "https://www.fda.gov/medical-devices/postmarket-requirements-devices/quality-system-qs-regulationmedical-device-good-manufacturing-practices", "publisher": { "@type": "Organization", "name": "FDA" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/form-483#term", "name": "FDA Form 483", "url": "https://medtechterms.com/terms/form-483" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/qsr#term", "name": "Quality System Regulation", "alternateName": "QSR / 21 CFR 820", "url": "https://medtechterms.com/terms/qsr" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Quality & Risk", "item": "https://medtechterms.com/terms?cat=Quality%20%26%20Risk" }, { "@type": "ListItem", "position": 4, "name": "Warning Letter", "item": "https://medtechterms.com/terms/warning-letter" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/warning-letter#faq", "mainEntity": [ { "@type": "Question", "name": "What is the primary purpose of an FDA Warning Letter?", "acceptedAnswer": { "@type": "Answer", "text": "An FDA Warning Letter serves to notify a regulated entity of significant deviations from regulatory requirements that, if not corrected, may result in enforcement actions. It is a formal communication demanding prompt corrective action." } }, { "@type": "Question", "name": "How quickly must a company respond to an FDA Warning Letter?", "acceptedAnswer": { "@type": "Answer", "text": "The FDA typically requests a response within 15 business days of receipt of the Warning Letter. This response should outline the corrective actions taken and a timeline for completion of any ongoing actions." } }, { "@type": "Question", "name": "Are FDA Warning Letters publicly accessible?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, FDA Warning Letters are publicly available on the FDA website. This public disclosure can impact a company's reputation and business operations." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Quality & Risk](/terms?cat=Quality%20%26%20Risk) 6. / 7. Warning Letter [All terms](/terms) Quality & Risk [Quality System](/ecosystems/quality-system)[Post-Market & Safety](/ecosystems/post-market-safety)[Global Markets](/ecosystems/global-markets) # Warning Letter Formal FDA notification of significant violations requiring prompt corrective action. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition An FDA Warning Letter is a notice to a regulated entity citing significant violations and requesting prompt corrective action, typically within 15 business days. What the regulation says The FDA issues Warning Letters to address violations of regulatory significance, as outlined in 21 CFR Part 820 for [Quality System Regulation](/terms/qsr), 21 CFR Part 4 for combination products, and other applicable regulations like those found in 21 CFR Parts 801 and 809 for [labeling](/terms/labeling) and advertising. These letters serve as official communications indicating that the agency believes violations may lead to enforcement action if not promptly corrected. The FDA Field Management Directive (FMD) 140 provides guidance regarding the issuance and content of Warning Letters. ## What this means in practice Warning Letters are public and can affect new submissions, imports, and reputation. Repeat or unresolved issues can lead to seizures or injunctions. ## Examples - A medical device manufacturer receives a Warning Letter citing violations of 21 CFR 820.30, Quality System Design Controls, for inadequate design validation procedures related to a new product being marketed. - A pharmaceutical company is issued a Warning Letter due to repeated observations of unsanitary conditions and manufacturing deficiencies, which violate 21 CFR 211, Current Good Manufacturing Practice for Finished Pharmaceuticals. - An online retailer receives a Warning Letter for illegally marketing unapproved MedTech products with unsubstantiated claims, constituting a violation of the Federal Food, Drug, and Cosmetic Act. Common pitfalls - • Assuming a Warning Letter is merely a suggestion, rather than a formal communication of regulatory non-compliance that demands a response. - • Failing to address all cited observations in the Warning Letter, which can lead to further enforcement actions. - • Submitting a response without sufficient evidence or documentation of corrective actions. - • Delaying the response past the specified timeframe, typically 15 business days, without prior communication and agreement with the FDA. - • Underestimating the public and business impact of a Warning Letter, including potential effects on stock prices, contractual agreements, and reputation. ## Frequently asked questions What is the primary purpose of an FDA Warning Letter? An FDA Warning Letter serves to notify a regulated entity of significant deviations from regulatory requirements that, if not corrected, may result in enforcement actions. It is a formal communication demanding prompt corrective action. How quickly must a company respond to an FDA Warning Letter? Are FDA Warning Letters publicly accessible? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Quality & Risk FDA Form 483 Notice of inspectional observations issued at the conclusion of an FDA inspection. ](/terms/form-483)[ Quality & Risk Quality System Regulation(QSR / 21 CFR 820) FDA's current good manufacturing practice (cGMP) requirements for medical devices. ](/terms/qsr) ### QMS Foundations · From this learning path [ Quality & Risk Complaint Handling Process for receiving, evaluating, and responding to device complaints. ](/terms/complaint-handling?from=qms-foundations)[ Quality & Risk Corrective and Preventive Action(CAPA) Systematic process to investigate and resolve quality issues and prevent recurrence. ](/terms/capa?from=qms-foundations)[ Quality & Risk Design Controls Structured process governing the design of medical devices. ](/terms/design-controls?from=qms-foundations)[ Quality & Risk Design History File(DHF) Compilation of records describing the design history of a finished device. ](/terms/design-history-file?from=qms-foundations) ### More in Quality & Risk · Same category [ Quality & Risk Quality Management System Regulation(QMSR) FDA's harmonized successor to the QSR, incorporating ISO 13485:2016 by reference. ](/terms/qmsr)[ Quality & Risk Verification & Validation(V&V) Confirming design outputs meet inputs (V) and that devices meet user needs (V). ](/terms/verification-validation) Cited by Where this term appears across MedTech Terms. Learning paths (1) - [QMS Foundations](/paths/qms-foundations)Lesson 10 of 10 Ecosystems (3) - [Quality System](/ecosystems/quality-system) - [Post-Market & Safety](/ecosystems/post-market-safety) - [Global Markets](/ecosystems/global-markets) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 FDA· 2 MDIC· 1 1. [1 FDA Warning Letters Verified FDA · fda.gov ](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) 2. [2 MDIC Case for Quality Verified MDIC · mdic.org ](https://mdic.org/program/case-for-quality/) 3. [3 FDA - Quality Systems Verified FDA · fda.gov ](https://www.fda.gov/medical-devices/postmarket-requirements-devices/quality-system-qs-regulationmedical-device-good-manufacturing-practices) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Tying cybersecurity into your QMS? We help align cybersecurity activities with ISO 13485 design controls and ISO 14971 risk management. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Quality & Risk Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=warning-letter) Learn in 60 seconds Card Lesson Quiz Formal FDA notification of significant violations requiring prompt corrective action. - · Warning Letters are public and can affect new submissions, imports, and reputation. - · Repeat or unresolved issues can lead to seizures or injunctions. Remember this Watch out: Assuming a Warning Letter is merely a suggestion, rather than a formal communication of regulatory non-compliance that demands a response. Related terms - [FDA Form 483 ](/terms/form-483) - [Quality System Regulation(QSR / 21 CFR 820) ](/terms/qsr) You may also need Auto-suggested from Quality & Risk and shared keywords. - [Customer Notification Letter ](/terms/customer-notification) - [Corrective and Preventive Action(CAPA) ](/terms/capa) - [CAPA Effectiveness Check ](/terms/capa-effectiveness) - [510(k) Summary vs 510(k) Statement ](/terms/510k-summary-vs-statement) - [PMA Supplement Types ](/terms/pma-supplement-types) - [Removal vs Correction (21 CFR 806) ](/terms/removal-vs-correction) [All Quality & Risk terms](/terms?cat=Quality%20%26%20Risk) From the Blue Goat network Related resources and services on this topic. - [ MedTech Truths Common misconceptions about medical device development - debunked. ](https://mdcmisconceptions.com) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)